Circle of Impact Leaders are business professionals and advocates leveraging their networks and influence to support Hope for Luka. Their efforts include:
Their contributions fund research, drive advocacy, and create a legacy of impact for muscular dystrophy patients worldwide.
Hello, my name is Kiani Komeizi, and I'd like to share a bit about how I know Mazi. We first met as minors in Vienna, both waiting for our refugee cases to be accepted so we could move to the U.S. We arrived in Houston with countless dreams and hopes for the future. Today, I’m incredibly proud of my long-time friend for never giving up on his son and for facing each challenge with determination every day. Mazi, I am honored to call you my friend.
Kiani Komeizi - Kiani Realty
Board member and newly appointed Executive Director of Hope for Luka Inc., Tushar Tangsali, father of two sons with exon 8-25 deletions, has spearheaded this initiative. Through extensive research, he aims to fund studies benefiting his children and others with mutations within the first 26 exons of the dystrophin gene.
Targeted Start Date: January 3rd, 2025
Estimated Timeline of ∆6-25 Mice Model Creation: March 31st, 2025
Number of Patients Exons 6 & 7 Skipping May Benefit: 180 Patients
∆6-25 Mice Model Cost (Campaign's Goal): $25,000
| Donate Below - Campaign's Goal: $25,000 |
|---|
| Donations Between: $25 to $100 |
| Donations Between: $150 to $700 |
| Donations Between: $1000 to $5K |
| Donations Between: $6000 to $20K |
Board member and newly appointed Executive Director of Hope for Luka Inc., Tushar Tangsali, father of two sons with exon 8-25 deletions, has spearheaded this initiative. Through extensive research, he aims to fund studies benefiting his children and others with mutations within the first 26 exons of the dystrophin gene.
Targeted Start Date: January 3rd, 2025
Estimated Timeline of ∆6-25 Mice Model Creation: March 31st, 2025
Number of Patients Exons 6 & 7 Skipping May Benefit: 180 Patients
∆6-25 Mice Model Cost (Campaign's Goal): $25,000
Fueling Cutting-Edge Research: The financial support and sponsorships secured by Circle of Impact Leaders directly fund research initiatives with the potential to bring forth muscular dystrophy treatments for rare mutations.
